Journal article
Association of Androgen Deprivation Therapy with Metabolic Disease in Prostate Cancer Patients: An Updated Meta-Analysis
Abstract
BACKGROUND: Androgen deprivation therapy (ADT), a backbone treatment for advanced prostate cancer (PC), is known to have a variety of metabolic side effects. We conducted an updated meta-analysis to quantify the metabolic risks of ADT.
MATERIALS AND METHODS: We searched PubMed, Web of Science, and Scopus in May of 2022 for studies investigating the risk of metabolic syndrome (MetS), diabetes, and hypertension from ADT in PC patients using …
Authors
Swaby J; Aggarwal A; Batra A; Jain A; Seth L; Stabellini N; Bittencourt MS; Leong D; Klaassen Z; Barata P
Journal
Clinical Genitourinary Cancer, Vol. 21, No. 3, pp. e182–e189
Publisher
Elsevier
Publication Date
6 2023
DOI
10.1016/j.clgc.2022.12.006
ISSN
1558-7673